Estado actual de la investigación en cirugía bariátrica

Referencias bibliográficas

• Deitel, M. and J. Melissas, The origin of the word "bari". Obes Surg, 2005. 15(7): p. 1005-8.
• Leroux, J.S., S. Moore, and L. Dube, Beyond the "I" in the obesity epidemic: a review of social relational and network interventions on obesity. J Obes, 2013. 2013: p. 348249.
• Bell, C.N., J. Kerr, and J.L. Young, Associations between Obesity, Obesogenic Environments, and Structural Racism Vary by County-Level Racial Composition. Int J Environ Res Public Health, 2019. 16(5).
• Suglia, S.F., et al., Why the Neighborhood Social Environment Is Critical in Obesity Prevention. J Urban Health, 2016. 93(1): p. 206-12.
• Finucane, M.M., et al., National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet, 2011. 377(9765): p. 557-67.
• Cheng, J., et al., The comprehensive summary of surgical versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomized controlled trials. Oncotarget, 2016. 7(26): p. 39216-39230.
• Mathus-Vliegen, E.M., Obesity and the elderly. J Clin Gastroenterol, 2012. 46(7): p. 533-44.
• Kelly, T., et al., Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond), 2008. 32(9): p. 1431-7.
• Kramer, C.K., B. Zinman, and R. Retnakaran, Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis. Ann Intern Med, 2013. 159(11): p. 758-69.
• Ma, C., et al., Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ, 2017. 359: p. j4849.
• Pearl, R.L., et al., Short- and Long-Term Changes in Health-Related Quality of Life with Weight Loss: Results from a Randomized Controlled Trial. Obesity (Silver Spring), 2018. 26(6): p. 985-991.
• Mendrick, D.L., et al., Metabolic Syndrome and Associated Diseases: From the Bench to the Clinic. Toxicol Sci, 2018. 162(1): p. 36-42.
• NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel. Ann Intern Med, 1991. 115(12): p. 956-61.
• Colquitt, J.L., et al., Surgery for weight loss in adults. Cochrane Database Syst Rev, 2014(8): p. CD003641.
• le Roux, C.W. and H.M. Heneghan, Bariatric Surgery for Obesity. Med Clin North Am, 2018. 102(1): p. 165-182.
• Pories, W.J., et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg, 1995. 222(3): p. 339-50; discussion 350-2.
• Billeter, A.T., et al., Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with type 2 diabetes mellitus. Br J Surg, 2018. 105(3): p. 168-181.
• Yan, Y., et al., Roux-en-Y Gastric Bypass Versus Medical Treatment for Type 2 Diabetes Mellitus in Obese Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Medicine (Baltimore), 2016. 95(17): p. e3462.
• Guo, L., et al., [Body mass index and cancer incidence:a prospective cohort study in northern China]. Zhonghua Liu Xing Bing Xue Za Zhi, 2014. 35(3): p. 231-6.
• Schiavon, C.A., et al., Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension). Circulation, 2018. 137(11): p. 1132-1142.
• Adams, T.D., et al., Weight and Metabolic Outcomes 12 Years after Gastric Bypass. N Engl J Med, 2017. 377(12): p. 1143-1155.
• Mechanick, J.I., et al., Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient--2013 update: cosponsored by American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic & Bariatric Surgery. Obesity (Silver Spring), 2013. 21 Suppl 1: p. S1-27.
• Telem D. Greenstein AJ, W.B. Medical outcomes following bariatric surgery. 2018; Available from: https://ws003.juntadeandalucia.es:2060/contents/medical-outcomes-following-bariatric-surgery.
• Ponce, J., et al., American Society for Metabolic and Bariatric Surgery estimation of bariatric surgery procedures in 2015 and surgeon workforce in the United States. Surg Obes Relat Dis, 2016. 12(9): p. 1637-1639.
• Arterburn, D.E. and A.P. Courcoulas, Bariatric surgery for obesity and metabolic conditions in adults. BMJ, 2014. 349: p. g3961.
• Hanipah, Z.N. and P.R. Schauer, Surgical Treatment of Obesity and Diabetes. Gastrointest Endosc Clin N Am, 2017. 27(2): p. 191-211.
• Gill, R.S., et al., The impact of bariatric surgery in patients with type-2 diabetes mellitus. Curr Diabetes Rev, 2011. 7(3): p. 185-9.
• Cummings, D.E. and F. Rubino, Metabolic surgery for the treatment of type 2 diabetes in obese individuals. Diabetologia, 2018. 61(2): p. 257-264.
• Koliaki, C., et al., The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord, 2017. 17(1): p. 50.
• 30. Akcay, M.N., E. Karadeniz, and A. Ahiskalioglu, Bariatric/Metabolic Surgery in Type 1 and Type 2 Diabetes Mellitus. Eurasian J Med, 2019. 51(1): p. 85-89.
• Ashrafian, H., et al., Type 1 Diabetes Mellitus and Bariatric Surgery: A Systematic Review and Meta-Analysis. Obes Surg, 2016. 26(8): p. 1697-704.
• Hussain, A., The effect of metabolic surgery on type 1 diabetes: meta-analysis. Arch Endocrinol Metab, 2018. 62(2): p. 172-178.
• Cohen, R.V., et al., Diabetes remission without weight loss after duodenal bypass surgery. Surg Obes Relat Dis, 2012. 8(5): p. e66-8.
• Cohen, R., P.P. Caravatto, and T.Z. Petry, Innovative metabolic operations. Surg Obes Relat Dis, 2016. 12(6): p. 1247-55.
• Astiarraga, B., et al., Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms. J Clin Endocrinol Metab, 2013. 98(7): p. 2765-73.
• Coelho, D., et al., Diabetes Remission Rate in Different Bmi Grades Following Roux-En-Y Gastric Bypass. Arq Bras Cir Dig, 2018. 31(1): p. e1343.
• Dong, Z., et al., Laparoscopic metabolic surgery for the treatment of type 2 diabetes in Asia: a scoping review and evidence-based analysis. BMC Surg, 2018. 18(1): p. 73.
• Menzo, E.L., et al., American Society for Metabolic and Bariatric Surgery and American Hernia Society consensus guideline on bariatric surgery and hernia surgery. Surg Obes Relat Dis, 2018. 14(9): p. 1221-1232.
• Bhandari, M., et al., Standardization of Bariatric Metabolic Procedures: World Consensus Meeting Statement. Obes Surg, 2019. 29(Suppl 4): p. 309-345.
• Ryan, D.H. and S. Kahan, Guideline Recommendations for Obesity Management. Med Clin North Am, 2018. 102(1): p. 49-63.
• Brito, J.P., V.M. Montori, and A.M. Davis, Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations. JAMA, 2017. 317(6): p. 635-636.
• Sabench Pereferrer, F., et al., Quality criteria in bariatric surgery: Consensus review and recommendations of the Spanish Association of Surgeons and the Spanish Society of Bariatric Surgery. Cir Esp, 2017. 95(1): p. 4-16.
• Lecube, A., et al., Prevention, diagnosis, and treatment of obesity. 2016 position statement of the Spanish Society for the Study of Obesity. Endocrinol Diabetes Nutr, 2017. 64 Suppl 1: p. 15-22.
• Vilallonga, R., et al., A Spanish Society joint SECO and SEEDO approach to the Post-operative management of the patients undergoing surgery for obesity. Obes Surg, 2019.
• Busetto, L., et al., Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management". Obes Surg, 2018. 28(7): p. 2117-2121.
• Fried, M., et al., Interdisciplinary European Guidelines on metabolic and bariatric surgery. Obes Facts, 2013. 6(5): p. 449-68.
• Vargas, E.J., et al., Medical Devices for Obesity Treatment: Endoscopic Bariatric Therapies. Med Clin North Am, 2018. 102(1): p. 149-163.
• Espinet Coll, E., et al., Spanish Consensus Document on Bariatric Endoscopy. Part 1. General considerations. Rev Esp Enferm Dig, 2018. 110(6): p. 386-399.
• Li, S.H., Y.J. Wang, and S.T. Zhang, Development of Bariatric and Metabolic Endoscopy. Chin Med J (Engl), 2018. 131(1): p. 88-94.
• Ruban, A., et al., Medical Devices in Obesity Treatment. Curr Diab Rep, 2019. 19(10): p. 90.
• Hill, C., et al., Endoluminal weight loss and metabolic therapies: current and future techniques. Ann N Y Acad Sci, 2018. 1411(1): p. 36-52.
• Storm, A.C. and C.C. Thompson, Endoscopic Treatments Following Bariatric Surgery. Gastrointest Endosc Clin N Am, 2017. 27(2): p. 233-244.
• Glaysher, M.A., et al., A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus. BMJ Open, 2017. 7(11): p. e018598.
• Peterli, R., et al., Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial. Obes Surg, 2012. 22(5): p. 740-8.
• Roth, C.L., et al., Ghrelin and obestatin levels in severely obese women before and after weight loss after Roux-en-Y gastric bypass surgery. Obes Surg, 2009. 19(1): p. 29-35.
• Cazzo, E., et al., GLP-1 and GLP-2 Levels are Correlated with Satiety Regulation After Roux-en-Y Gastric Bypass: Results of an Exploratory Prospective Study. Obes Surg, 2017. 27(3): p. 703-708.
• Svane, M.S., et al., Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes (Lond), 2016. 40(11): p. 1699-1706.
• Goldstone, A.P., et al., Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity. J Clin Endocrinol Metab, 2016. 101(2): p. 599-609.
• Crujeiras, A.B., et al., Plasma FGF21 levels in obese patients undergoing energy-restricted diets or bariatric surgery: a marker of metabolic stress? Int J Obes (Lond), 2017. 41(10): p. 1570-1578.
• Ejarque, M., et al., Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery. Transl Res, 2017. 184: p. 35-44 e4.
• Krist, J., et al., Effects of weight loss and exercise on apelin serum concentrations and adipose tissue expression in human obesity. Obes Facts, 2013. 6(1): p. 57-69.
• Hallberg, S.J., et al., Reversing Type 2 Diabetes: A Narrative Review of the Evidence. Nutrients, 2019. 11(4).
• Bueter, M., et al., Renal cytokines improve early after bariatric surgery. Br J Surg, 2010. 97(12): p. 1838-44.
• Balsa, J.A., et al., The role of serum osteoprotegerin and receptor-activator of nuclear factor-kappaB ligand in metabolic bone disease of women after obesity surgery. J Bone Miner Metab, 2016. 34(6): p. 655-661.
• Gagnon, C. and A.L. Schafer, Bone Health After Bariatric Surgery. JBMR Plus, 2018. 2(3): p. 121-133.
• Liu, H., et al., Role of gut microbiota, bile acids and their cross-talk in the effects of bariatric surgery on obesity and type 2 diabetes. J Diabetes Investig, 2018. 9(1): p. 13-20.
• Wang, W., et al., Role of Bile Acids in Bariatric Surgery. Front Physiol, 2019. 10: p. 374.
• Rao, R.S., Bariatric surgery and the central nervous system. Obes Surg, 2012. 22(6): p. 967-78.
• Berthoud, H.R., A.C. Shin, and H. Zheng, Obesity surgery and gut-brain communication. Physiol Behav, 2011. 105(1): p. 106-19.
• Camastra, S., et al., Muscle and adipose tissue morphology, insulin sensitivity and beta-cell function in diabetic and nondiabetic obese patients: effects of bariatric surgery. Sci Rep, 2017. 7(1): p. 9007.
• Chabot, K., et al., Evolution of subcutaneous adipose tissue fibrosis after bariatric surgery. Diabetes Metab, 2017. 43(2): p. 125-133.
• du Plessis, J., et al., Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. Gastroenterology, 2015. 149(3): p. 635-48 e14.
• Spoto, B., et al., Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity. Nutr Metab Cardiovasc Dis, 2014. 24(10): p. 1137-43.
• Chasapi, A., et al., Can obesity-induced inflammation in skeletal muscle and intramuscular adipose tissue accurately detect liver fibrosis? J Musculoskelet Neuronal Interact, 2018. 18(4): p. 509-524.
• Saafan, T., W. El Ansari, and M. Bashah, Compared to What? Is BMI Associated with Histopathological Changes in Laparoscopic Sleeve Gastrectomy Specimens? Obes Surg, 2019. 29(7): p. 2166-2173.
• Nogueira Tde, B., et al., H. pylori infection, endoscopic, histological aspects and cell proliferation in the gastric mucosa of patients submitted to roux-en-y gastric bypass with contention ring: a cross sectional endoscopic and immunohistochemical study. Arq Gastroenterol, 2016. 53(1): p. 55-60.
• Rumilla, K.M., et al., Hyperinsulinemic hypoglycemia with nesidioblastosis: histologic features and growth factor expression. Mod Pathol, 2009. 22(2): p. 239-45.
• Service, G.J., et al., Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med, 2005. 353(3): p. 249-54.
• Rubino, F., Is type 2 diabetes an operable intestinal disease? A provocative yet reasonable hypothesis. Diabetes Care, 2008. 31 Suppl 2: p. S290-6.
• Rubino, F. and J. Marescaux, Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg, 2004. 239(1): p. 1-11.
• Rubino, F., et al., The mechanism of diabetes control after gastrointestinal bypass surgery reveals a role of the proximal small intestine in the pathophysiology of type 2 diabetes. Ann Surg, 2006. 244(5): p. 741-9.
• Camacho-Ramirez, A., et al., Bariatric surgery influences beta-cell turnover in non obese rats. Histol Histopathol, 2017. 32(12): p. 1341-1350.
• Shimizu, H., et al., The effect of selective gut stimulation on glucose metabolism after gastric bypass in the Zucker diabetic fatty rat model. Surg Obes Relat Dis, 2014. 10(1): p. 29-35.
• Salinari, S., et al., Duodenal-jejunal bypass and jejunectomy improve insulin sensitivity in Goto-Kakizaki diabetic rats without changes in incretins or insulin secretion. Diabetes, 2014. 63(3): p. 1069-78.
• Prada-Oliveira, J.A., et al., GLP-1 mediated improvement of the glucose tolerance in the T2DM GK rat model after massive jejunal resection. Ann Anat, 2019. 223: p. 1-7.
• Camacho-Ramirez, A., et al., The histomorphometric parameters of endocrine pancreas after bariatric surgery in healthy animal models. Tissue Cell, 2019. 57: p. 78-83.
• Moreno-Arciniegas, A., et al., The main participation of the enterohormone GLP-1 after bariatric surgery. Minerva Chir, 2019. 74(1): p. 7-13.
• Grong, E., et al., Sleeve gastrectomy, but not duodenojejunostomy, preserves total beta-cell mass in Goto-Kakizaki rats evaluated by three-dimensional optical projection tomography. Surg Endosc, 2016. 30(2): p. 532-542.
• Sharkey, K.A., Animal models of bariatric/metabolic surgery shed light on the mechanisms of weight control and glucose homeostasis: view from the chair. Int J Obes (Lond), 2011. 35 Suppl 3: p. S31-4.
• Perez-Arana, G., et al., A surgical model of short bowel syndrome induces a long-lasting increase in pancreatic beta-cell mass. Histol Histopathol, 2015. 30(4): p. 479-87.